Three melanoma cell lines were treated with curcumin and it has shown a decreasing of NF-κB binding activity through electrophoretic mobility shift assay (EMSA), and an inhibition of cell viability in a dose-dependent manner with IC50 ranging from 6.1 μM to 7.7 μM [48]. This evidence concerns the gene NFKB1 and melanoma.